Independent publication · Affiliate-supported · Not medical advice
Wave 1

Semaglutide vs Tirzepatide: What’s Different?

A high-level comparison of semaglutide and tirzepatide that focuses on drug class, approved products and why clinician guidance matters.

Reviewed August 26, 2026 · General information only

Medical information notice: This page is educational, not medical advice. Compounded medications are not FDA-approved. A licensed clinician should determine whether prescription treatment is appropriate for you.

Key points

  • Semaglutide and tirzepatide are different prescription medicines with different mechanisms and approved product labeling.
  • Treatment selection depends on individual medical circumstances, contraindications, product availability and clinician judgment.
  • This site does not recommend one prescription drug over another for an individual.

How to use this guide

Use this article to prepare questions and understand terminology, then rely on your licensed clinician, dispensing pharmacy, FDA-approved labeling where applicable, and current FDA guidance for medication-specific decisions.

What to verify before making a decision

Confirm the exact product, FDA approval status, prescriber, dispensing pharmacy, total amount billed today, renewal terms, cancellation rules and available clinical follow-up. Program terms can change, so merchant-specific claims should be checked at the source.

Related guides

Sources & update standard

Merchant-specific claims are based on HealthRX’s currently published materials. Regulatory distinctions are checked against FDA materials. We date-stamp substantive reviews because pricing, supply conditions and compounding policy can change.

See HealthRX Plans